BackLexaria Bioscience - Warrants (11/01/2026) Overview
Lexaria Bioscience Corp - Warrants (11/01/2026)

Lexaria Bioscience - Warrants (11/01/2026) Discounted Cash Flow

DCF Analysis for LEXXW.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-1.66

Current Fair Value

$-1.66
138775.0% Downside

Overvalued by 138775.0% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading